Signal detection of adverse drug reaction to first line anti tuberculosis drugs using the Indonesian pharmacovigilance database

Author:

Utami Setyo,Athiyah Umi,Nita Yunita

Abstract

Introduction: Pharmacovigilance is a key component to identify risks associated with drug use. The safety of antituberculosis drugs (ATDs) is a concern.     Aim: To detect first-line ATD signals in the Indonesian pharmacovigilance database.    Methods: A retrospective cohort with a sample report of ADRs obtained from the National Agency of Drug and Food Control (NADFC) from 2012 to May 2018. The validity was seen from the completeness of the data. The signals found were verified against registered product labels, books, and reports from other countries' databases.    Results: ATD ADRs reported was 5.3%. The ATD that met the requirements as a signal was rash maculopapular (PRR 4.53; ROR 6.19; IC 0.74 and p=035) for Rifampicin-Isoniazid-Pyrazinamide-Ethambutol (RHZE) and rash (PRR 2.94; ROR 4.23; IC 1.41 and p=0.046) for RH.    Conclusion: Safety signals detected in the Indonesian pharmacovigilance database between 2012 and May 2018 were rash maculopapular.

Publisher

International Pharmaceutical Federation (FIP)

Subject

Pharmaceutical Science,Pharmacy,Education,Pharmaceutical Science,Pharmacy,Education

Reference24 articles.

1. Andrews, B. E; Moore, N. (ed.) (2014) Mann’s Pharmacovigilance. 3rd ed. West Sussex, UK: Wiley Blackwell, ha. 1-354. https://doi.org/10.1002/9781118820186

2. Athira, B., Cs, M. and Jyothi, E. (2015) “A study on adverse drug reactions to first-line antitubercular drugs in DOTS therapy,” International Journal of Pharmacology and Clinical Sciences March, 4(1), p. 7–11

3. Badan POM RI (2017a) “Profil Laporan Efek Samping Obat Tahun 2016 (1),” Buletin Berita MESO. 35 No. 1, hal. 7–8. doi: ISSN: 08526184

4. Badan POM RI (2017b) e-meso.pom.go.id. Tersedia pada: e-meso.pom.go.id

5. Böhm, R. (2015) “Primer on Disproportionality Analysis,” Openvigil, p 1-10, Tersedia pada: openvigil.sourceforge.net/doc/DPA.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3